Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Recent advances in the management of chronic obstructive pulmonary disease.

Rosenberg SR, Kalhan R.

F1000Res. 2017 Jun 9;6:863. doi: 10.12688/f1000research.9819.1. eCollection 2017. Review.

2.

The Global Lung Function Initiative 2012 Equations Are as Well-Suited as Local Population Derived Equations to a Sample of Healthy Professional Firefighters.

Slattery F, Schermer T, Esterman A, Johnston K, Crockett A.

Can Respir J. 2017;2017:6327180. doi: 10.1155/2017/6327180. Epub 2017 May 25.

3.

Self-Management Support Using a Digital Health System Compared With Usual Care for Chronic Obstructive Pulmonary Disease: Randomized Controlled Trial.

Farmer A, Williams V, Velardo C, Shah SA, Yu LM, Rutter H, Jones L, Williams N, Heneghan C, Price J, Hardinge M, Tarassenko L.

J Med Internet Res. 2017 May 3;19(5):e144. doi: 10.2196/jmir.7116.

4.

Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD.

Thulborn SJ, Dilpazir M, Haldar K, Mistry V, Brightling CE, Barer MR, Bafadhel M.

Int J Chron Obstruct Pulmon Dis. 2017 Apr 18;12:1199-1205. doi: 10.2147/COPD.S123528. eCollection 2017.

5.

Hospital readmissions for COPD: a retrospective longitudinal study.

Harries TH, Thornton H, Crichton S, Schofield P, Gilkes A, White PT.

NPJ Prim Care Respir Med. 2017 Apr 27;27(1):31. doi: 10.1038/s41533-017-0028-8.

6.

Respiratory health screening for opiate misusers in a specialist community clinic: a mixed-methods pilot study, with integrated staff and service user feedback.

Mitchell CA, Pitt A, Hulin J, Lawson R, Ashby F, Appelqvist I, Delaney B.

BMJ Open. 2016 Oct 14;6(10):e012823. doi: 10.1136/bmjopen-2016-012823.

7.

Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study.

Price DB, Russell R, Mares R, Burden A, Skinner D, Mikkelsen H, Ding C, Brice R, Chavannes NH, Kocks JW, Stephens JW, Haughney J.

PLoS One. 2016 Sep 22;11(9):e0162903. doi: 10.1371/journal.pone.0162903. eCollection 2016.

8.

Using Big Data to Assess Prescribing Patterns in Greece: The Case of Chronic Obstructive Pulmonary Disease.

Souliotis K, Kani C, Papageorgiou M, Lionis D, Gourgoulianis K.

PLoS One. 2016 May 18;11(5):e0154960. doi: 10.1371/journal.pone.0154960. eCollection 2016.

9.

Effect of low-intensity continuous training on lung function and cardiorespiratory fitness in both cigarette and hookah smokers.

Koubaa A, Triki M, Trabelsi H, Masmoudi L, Zeghal KN, Sahnoun Z, Hakim A.

Afr Health Sci. 2015 Dec;15(4):1170-81. doi: 10.4314/ahs.v15i4.16.

10.

Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial.

Hitchings AW, Lai D, Jones PW, Baker EH; Metformin in COPD Trial Team.

Thorax. 2016 Jul;71(7):587-93. doi: 10.1136/thoraxjnl-2015-208035. Epub 2016 Feb 25.

11.

Towards integration of palliative care in patients with chronic heart failure and chronic obstructive pulmonary disease: a systematic literature review of European guidelines and pathways.

Siouta N, van Beek K, Preston N, Hasselaar J, Hughes S, Payne S, Garralda E, Centeno C, van der Eerden M, Groot M, Hodiamont F, Radbruch L, Busa C, Csikos A, Menten J.

BMC Palliat Care. 2016 Feb 13;15:18. doi: 10.1186/s12904-016-0089-4. Review.

12.

One-year mortality associated with COPD treatment: a comparison of tiotropium and long-acting beta2-agonists in three Italian regions: results from the OUTPUL study.

Kirchmayer U, Cascini S, Agabiti N, Di Martino M, Bauleo L, Formoso G, Voci C, Pistelli R, Patorno E, Davoli M; OUTPUL study group.

Pharmacoepidemiol Drug Saf. 2016 May;25(5):578-89. doi: 10.1002/pds.3961. Epub 2016 Jan 29.

13.
14.

Outcome of Inhaler Withdrawal in Patients Receiving Triple Therapy for COPD.

Kim SA, Lee JH, Kim EK, Kim TH, Kim WJ, Lee JH, Yoon HI, Baek S, Lee JS, Oh YM, Lee SD.

Tuberc Respir Dis (Seoul). 2016 Jan;79(1):22-30. doi: 10.4046/trd.2016.79.1.22. Epub 2015 Dec 31. Erratum in: Tuberc Respir Dis (Seoul). 2016 Jul;79(3):193.

15.

Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD.

Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R, Wijesinghe M, Harrison RN, Steen N, Simpson AJ, Gibson GJ, Bourke SC.

Thorax. 2016 Feb;71(2):133-40. doi: 10.1136/thoraxjnl-2015-207775.

16.

Differential pharmacology and clinical utility of long-acting bronchodilators in COPD - focus on olodaterol.

Matera MG, Ora J, Cazzola M.

Ther Clin Risk Manag. 2015 Dec 4;11:1805-11. doi: 10.2147/TCRM.S73581. eCollection 2015. Review.

17.

Validity, Reliability, and Responsiveness of the Dutch Version of the London Chest Activity of Daily Living Scale in Patients With Severe COPD.

Klijn P, Legemaat M, Beelen A, Keimpema Av, Garrod R, Bergsma M, Paterson B, Stuijfzand A, van Stel H.

Medicine (Baltimore). 2015 Dec;94(49):e2191. doi: 10.1097/MD.0000000000002191.

18.

Should pulse oximetry be included in GPs' assessment of patients with obstructive lung disease?

Dalbak LG, Straand J, Melbye H.

Scand J Prim Health Care. 2015;33(4):305-10. doi: 10.3109/02813432.2015.1117283. Epub 2015 Dec 11.

19.

Using venous blood gas analysis in the assessment of COPD exacerbations: a prospective cohort study.

McKeever TM, Hearson G, Housley G, Reynolds C, Kinnear W, Harrison TW, Kelly AM, Shaw DE.

Thorax. 2016 Mar;71(3):210-5. doi: 10.1136/thoraxjnl-2015-207573. Epub 2015 Dec 1.

20.

Diagnostic accuracy of screening tests for COPD: a systematic review and meta-analysis.

Haroon S, Jordan R, Takwoingi Y, Adab P.

BMJ Open. 2015 Oct 8;5(10):e008133. doi: 10.1136/bmjopen-2015-008133. Review.

Supplemental Content

Support Center